Zymeworks (Zyme) 2026 Earnings: An Investor Guidebook
As Zymeworks gears up for 2026 earnings, investors should focus on cash runway, pipeline milestones, and collaboratio...
Index funds offer low fees and broad diversification, making them a solid default choice for long-term investors.
26,735 articlesAs Zymeworks gears up for 2026 earnings, investors should focus on cash runway, pipeline milestones, and collaboratio...
When a notable hedge fund exits a sizable stake, it prompts questions about the underlying thesis. This article digs ...
A troubling local case shows how a fake voter guide can blend into the political scene and affect your finances. Lear...
A 2026 wave of disclosures shows universities reevaluating ties to Jeffrey Epstein’s fundraising network, prompting r...
When digital assets are seized, custody rules matter as much as the seizure itself. This article breaks down what hap...
Investors chasing high-tech breakthroughs often bet on early-stage companies like Rigetti. This article breaks down w...
When a mining stock pops today, investors sit up. Discover the drivers behind SSR Mining's rally, what it means for r...
In a market rattled by softer data, Coca-Cola’s traditional strengths keep drawing new and seasoned investors alike. ...
Tesla's latest moves in robotaxi expansion and a tease of a big announcement sparked a rally. Learn what drove the ju...
Flat home prices “mirror” a familiar 1990s pattern, signaling subtle shifts for buyers and investors. This article un...
A major enterprise contract could transform D-Wave from a hardware play into a recurring-revenue champion. This artic...
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...